{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:14:57Z","timestamp":1786331697895,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1097\/jcma.0000000000000050","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:09:06Z","timestamp":1553731746000},"page":"256-259","source":"Crossref","is-referenced-by-count":8,"title":["Uninterrupted non\u2013vitamin K antagonist oral anticoagulants during implantation of cardiac implantable electronic devices in patients with atrial fibrillation"],"prefix":"10.1097","volume":"82","author":[{"given":"Chuan-Tsai","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Nan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze-Fan","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yenn-Jiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Lin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wei","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Feng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-Po","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Chuan","family":"Tuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ann","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210129","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"key":"R2-3-20210129","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1056\/NEJMoa1302946","article-title":"Pacemaker or defibrillator surgery without interruption of anticoagulation.","volume":"368","author":"Birnie","year":"2013","journal-title":"N Engl J Med"},{"key":"R3-3-20210129","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.","volume":"17","author":"Heidbuchel","year":"2015","journal-title":"Europace"},{"key":"R4-3-20210129","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"R5-3-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1540-8159.2007.00943.x","article-title":"Lead perforation: incidence in registries.","volume":"31","author":"Carlson","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"R6-3-20210129","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jacc.2016.01.009","article-title":"Clinically significant pocket hematoma increases long-term risk of device infection: BRUISE CONTROL INFECTION study.","volume":"67","author":"Essebag","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R7-3-20210129","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/clc.22554","article-title":"Postoperative strokes and intracranial bleeds in patients with atrial fibrillation: the fibstroke study.","volume":"39","author":"Palomaki","year":"2016","journal-title":"Clin Cardiol"},{"key":"R8-3-20210129","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary.","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"key":"R9-3-20210129","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.","volume":"64","author":"January","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R10-3-20210129","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/imj.12448","article-title":"New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural\/bleeding management. Australasian Society of Thrombosis and Haemostasis.","volume":"44","author":"Tran","year":"2014","journal-title":"Intern Med J"},{"key":"R11-3-20210129","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.cjca.2016.07.591","article-title":"Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.","volume":"32","author":"Macle","year":"2016","journal-title":"Can J Cardiol"},{"key":"R12-3-20210129","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jfma.2016.10.005","article-title":"Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation.","volume":"115","author":"Chiang","year":"2016","journal-title":"J Formos Med Assoc"},{"key":"R13-3-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.joa.2017.05.004","article-title":"consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.","volume":"33","author":"Chiang","year":"2017","journal-title":"J Arrhythm"},{"key":"R14-3-20210129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cjca.2013.11.027","article-title":"Managing novel oral anticoagulants in patients with atrial fibrillation undergoing device surgery: Canadian survey.","volume":"30","author":"Nascimento","year":"2014","journal-title":"Can J Cardiol"},{"key":"R15-3-20210129","first-page":"1630","article-title":"Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial.","volume":"19","author":"Essebag","year":"2017","journal-title":"Eur Soc Cardiol"},{"key":"R16-3-20210129","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1160\/TH14-04-0305","article-title":"Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.","volume":"113","author":"Douketis","year":"2015","journal-title":"Thromb Haemost"},{"key":"R17-3-20210129","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.amjcard.2012.12.046","article-title":"Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices.","volume":"111","author":"Rowley","year":"2013","journal-title":"Am J Cardiol"},{"key":"R18-3-20210129","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/jce.12214","article-title":"Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.","volume":"24","author":"Jennings","year":"2013","journal-title":"Cardiovasc Electrophysiol"},{"key":"R19-3-20210129","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/europace\/euw127","article-title":"Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).","volume":"18","author":"Deharo","year":"2016","journal-title":"Europace"}],"container-title":["Journal of the Chinese Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCMA.0000000000000050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:33:59Z","timestamp":1620956039000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02118582-201904000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/jcma.0000000000000050","relation":{},"ISSN":["1726-4901"],"issn-type":[{"value":"1726-4901","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}